Madeira nun remains stable after 2024 threat
ScienceMadeira

Madeira nun remains stable after 2024 threat

SAPO Notícias3 September 2026 at 12:19

The Madeiran petrel, a seabird endemic to the Madeira archipelago, continues to have a stable population, despite a 2024 fire that threatened its nesting area. The Institute of Forests and Nature Conservation indicated that the species, classified as in danger of extinction, managed to maintain its numbers without significant change.

Last year's fire represented a significant threat to the habitat where this bird nests, raising concerns about the future of the species. However, the latest data shows that the population did not suffer the negative impacts that had been feared.

The Institute of Forests and Nature Conservation is the body responsible for monitoring this seabird situation in the archipelago. This entity is tasked with assessing the conservation status of the species and coordinating efforts for its protection.

The stability of the Madeiran petrel population is a positive sign for the conservation of this endemic species, although it remains in danger of extinction and continues to require ongoing protection measures.

Related articles

Science

Vaccination against syncytial virus starts on the 16th

The seasonal pediatric vaccination campaign against respiratory syncytial virus starts on the 16th and runs until March 31, 2027. The Directorate-General for Health expects all babies to be eligible for this seasonal RSV vaccination.

Observador03/09/26, 13:32
Comienza el ensayo en humanos de terapia génica nacida en España frente al alzhéimer: mejora la memoria y la neuroinflamación
Science

Human trial begins for Spanish-born gene therapy against Alzheimer's: improves memory and neuroinflammation

A promising gene therapy against moderate Alzheimer's, developed over 14 years ago at the Cajal Institute of the CSIC in Madrid, is set to begin human testing in Australia. The biotech company Tetraneuron received authorization from Australian health authorities to initiate the first clinical study of the TET-101 therapy, which will be conducted at St Vincent's Hospital in Melbourne. Pre-clinical trials demonstrated improvements in memory and neuroinflammation.

El Periódico Mediterráneo - General03/09/26, 13:25
Science

EU allocates €705 million to 421 young researchers, one with a project at Nova in Lisbon

The European Research Council allocated €705 million to 421 early-career researchers through funding grants, an investment aimed at supporting innovative projects in various fields of knowledge. Among the recipients is a researcher with a project to be developed at Universidade Nova de Lisboa, reinforcing Portugal's position in the European scientific landscape. The European Commission announced this allocation as part of the Horizon Europe programme.

Açoriano Oriental03/09/26, 13:10
FIGUEIRA DE CASTELO RODRIGO: Plataforma de Ciência Aberta promove verão com atividades gratuitas ligadas à natureza e à ciência
Science

FIGUEIRA DE CASTELO RODRIGO: Open Science Platform promotes summer with free activities linked to nature and science

The Open Science Platform of Figueira de Castelo Rodrigo prepared a summer program with free activities that aim to bring the population closer to nature and the region's science. The program includes twilight walks at Faia Brava and guided visits to the rock engravings of the Côa Valley, experiences intended for participants of different ages.

SAPO Notícias03/09/26, 13:03